Tag: European Academy of Allergy Asthma and Immunology (EAACI)

Research

Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...

News Wire ~ 3rd Party Press Release -
Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and current asthma.
AR101

Phase 3 Trial Data Demonstrates Consistent Safety and Efficacy of AR101...

Dave -
“Results of the European ARTEMIS trial provide further clinical validation of the safety and efficacy of AR101 for children and adolescents with peanut allergy.”
AR101

European Phase 3 Trial of AR101 Peanut OIT Candidate Meets Primary...

News Wire ~ 3rd Party Press Release -
Company Intends to Submit European MAA in Mid-2019.
Paliforzia (AR101)

Peanut OIT Phase 3 Trial Results Show Therapy Effective for Ages...

Dave -
Aimmune plans to submit a Biologics License Application for AR101 to the FDA by the end of 2018.
SnackSafely.com

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

©2019 SnackSafely.com Inc. All rights reserved.